BAM
MRK icon

Bruderman Asset Management’s Merck MRK Stock Holding History

Bruderman Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.13M Sell
12,415
-706
-5% -$62.6K 2.03% 16
2022
Q1 		$1.08M Sell
13,121
-10,225
-44% -$806K 1.62% 20
2021
Q4 		$1.79M Sell
23,346
-38,519
-62% -$3.07M 1.37% 23
2021
Q3 		$4.65M Buy
61,865
+656
+1% +$49.9K 1.17% 29
2021
Q2 		$4.76M Sell
61,209
-2,673
-4% -$199K 1.47% 27
2021
Q1 		$4.7M Buy
63,882
+1,186
+2% +$87.5K 1.31% 28
2020
Q4 		$4.89M Buy
62,696
+2,901
+5% +$222K 1.42% 25
2020
Q3 		$4.73M Sell
59,795
-57,753
-49% -$4.52M 1.55% 23
2020
Q2 		$8.76M Buy
117,548
+1,912
+2% +$144K 2.9% 7
2020
Q1 		$8.14M Buy
115,636
+1,429
+1% +$112K 3.23% 6
2019
Q4 		$10M Sell
114,207
-6,985
-6% -$574K 3.13% 4
2019
Q3 		$9.67M Sell
121,192
-12,448
-9% -$998K 2.44% 9
2019
Q2 		$10.7M Sell
133,640
-988
-0.7% -$75.7K 2.52% 11
2019
Q1 		$10.7M Sell
134,628
-27,948
-17% -$2.09M 2.34% 13
2018
Q4 		$11.9M Sell
162,576
-5,513
-3% -$389K 3.06% 5
2018
Q3 		$11.4M Buy
168,089
+90,161
+116% +$5.74M 2.61% 9
2018
Q2 		$4.51M Buy
77,928
+34,445
+79% +$1.94M 1.1% 37
2018
Q1 		$2.26M Buy
43,483
+27,467
+171% +$1.48M 0.54% 51
2017
Q4 		$860K Sell
16,016
-957
-6% -$53.1K 0.22% 75
2017
Q3 		$1.04M Sell
16,973
-789
-4% -$47.8K 0.27% 65
2017
Q2 		$1.09M Sell
17,762
-47
-0.3% -$2.86K 0.29% 64
2017
Q1 		$1.08M Sell
17,809
-38,580
-68% -$2.34M 0.31% 61
2016
Q4 		$3.17M Sell
56,389
-902
-2% -$52.8K 0.95% 32
2016
Q3 		$3.41M Sell
57,291
-579
-1% -$33.9K 1.02% 30
2016
Q2 		$3.18M Sell
57,870
-1,187
-2% -$63.2K 1% 29
2016
Q1 		$2.98M Buy
59,057
+4,153
+8% +$203K 1.04% 28
2015
Q4 		$2.77M Buy
54,904
+35,447
+182% +$1.79M 1.04% 26
2015
Q3 		$917K Sell
19,457
-145
-0.7% -$7.7K 0.36% 54
2015
Q2 		$1.06M Buy
19,602
+111
+0.6% +$6.22K 0.41% 53
2015
Q1 		$1.07M Buy
+19,491
New +$1.1M 0.42% 52

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bruderman Asset Management's MRK Position: Q2 2022 in Review

Bruderman Asset Management reduced its Merck (MRK) stake by 5.4% in Q2 2022, selling an estimated $62.6K and leaving 12,415 shares worth $1.13M. The position accounts for 2.03% of the portfolio, ranked #16.

Bruderman Asset Management first reported a position in MRK in Q1 2015 and has held it in 30 quarters since. The position peaked at $11.9M in Q4 2018. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Bruderman Asset Management held 12,415 shares of Merck worth $1.13M as of Q2 2022.
  • Bruderman Asset Management sold 706 Merck shares in Q2 2022, an estimated $62.6K.
  • Merck made up 2.03% of Bruderman Asset Management's portfolio in Q2 2022, its #16 holding.
  • Bruderman Asset Management first reported a position in Merck in Q1 2015 and has held it in 30 quarters since.
  • Bruderman Asset Management's Merck position peaked at $11.9M in Q4 2018.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Bruderman Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.